Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Spectranetics Eyes Double-Digit Growth in 2002 and 2003

Facebook Twitter LinkedIn Email Comments
COLORADO SPRINGS, Colo., Feb. 11 -- The Spectranetics Corp. said it intends to place 30-50 new lasers this year in order to strengthen its market position before the FDA approves peripheral atherectomy in the legs, which it expects to receive in 2003.

Joseph A. Largey, president and chief executive officer of Spectranetics, said, "Spectranetics successfully implemented a financial turnaround in 2001, achieving profitability and positive cash flow. In 2002, making our lasers available to the medical community is critical. We are targeting high-volume medical facilities that can use our laser for multiple applications, including coronary atherectomy and lead removal, and that show significant potential for peripheral atherectomy once we receive FDA approval."


Photonics.com
Feb 2002
News & Featureslasers

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.